Two retrospective studies, involving 102 cases and 66 cases, respectively, have reported that FOXP3 + cells infiltration had an independently positive prognostic impact on patients with stages I to III SCLC [75, 76]. The gene discussed is FOXP3; the disease is small cell lung carcinoma.